Format

Send to

Choose Destination
Nature. 2019 Dec;576(7785):143-148. doi: 10.1038/s41586-019-1785-z. Epub 2019 Nov 27.

Bile acid metabolites control TH17 and Treg cell differentiation.

Author information

1
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
2
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
3
Department of Biological Sciences, Birla Institute of Technology and Science, Hyderabad, India.
4
Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
5
Department of Chemistry, Bucknell University, Lewisburg, PA, USA.
6
The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY, USA.
7
Immunobiology and Microbial Pathogenesis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA.
8
Jill Roberts Center for IBD, Weill Cornell Medicine, New York, NY, USA.
9
Department of Bioengineering, Stanford University, Stanford, CA, USA. fischbach@fischbachgroup.org.
10
The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY, USA. Dan.Littman@med.nyu.edu.
11
Howard Hughes Medical Institute, New York, NY, USA. Dan.Littman@med.nyu.edu.
12
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. jun_huh@hms.harvard.edu.
13
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. jun_huh@hms.harvard.edu.

Abstract

Bile acids are abundant in the mammalian gut, where they undergo bacteria-mediated transformation to generate a large pool of bioactive molecules. Although bile acids are known to affect host metabolism, cancer progression and innate immunity, it is unknown whether they affect adaptive immune cells such as T helper cells that express IL-17a (TH17 cells) or regulatory T cells (Treg cells). Here we screen a library of bile acid metabolites and identify two distinct derivatives of lithocholic acid (LCA), 3-oxoLCA and isoalloLCA, as T cell regulators in mice. 3-OxoLCA inhibited the differentiation of TH17 cells by directly binding to the key transcription factor retinoid-related orphan receptor-γt (RORγt) and isoalloLCA increased the differentiation of Treg cells through the production of mitochondrial reactive oxygen species (mitoROS), which led to increased expression of FOXP3. The isoalloLCA-mediated enhancement of Treg cell differentiation required an intronic Foxp3 enhancer, the conserved noncoding sequence (CNS) 3; this represents a mode of action distinct from that of previously identified metabolites that increase Treg cell differentiation, which require CNS1. The administration of 3-oxoLCA and isoalloLCA to mice reduced TH17 cell differentiation and increased Treg cell differentiation, respectively, in the intestinal lamina propria. Our data suggest mechanisms through which bile acid metabolites control host immune responses, by directly modulating the balance of TH17 and Treg cells.

PMID:
31776512
PMCID:
PMC6949019
[Available on 2020-05-27]
DOI:
10.1038/s41586-019-1785-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center